mrmichaelfreedmen
Senior Member
- Messages
- 173
- Location
- Australia
Fantastic post @Jesse2233! You do indeed get the greatest information from Dr Chia.
Yes, Dr William Weir reports that his ME/CFS patients only started seeing signs of recovery around the 3rd or 4th month on tenofovir. Although Dr Weir says that some patients had IRIS-like features during the initial three months of treatment (the IRIS-like features might be an early indication of the drug working, but I am not clear whether these features were only present in patients who later went on to get a beneficial response from tenofovir, or whether these features were also present in patients who ultimately did not benefit from this drug).
Dr Weir's report is here:
Weir, William RC, FRCP FRCP (Edin).
Subject: Successful treatment of ME/CFS with antiretroviral
I am an infectious disease physician with an interest in ME/CFS. I am retired from the UK National Health Service now but retain my interest in ME/CFS and continue to see and treat patients with this condition. I wish to report some preliminary observations.
I have prescribed the antiretroviral, tenofovir, in the treatment of ME/CFS. I have three patients with ME/CFS who recovered whilst being given this drug. Signs of recovery did not appear until the third/fourth month. Two of them had IRIS like features during the first three months of treatment reminiscent of what I have seen in the treatment of HIV infection. I have also had to stop the tenofovir in 3 other patients in whom there was no beneficial response after 5 months. One of these was also having severe IRIS like symptoms and felt unable to carry on with the drug. In the recovered patients, I think placebo response was an unlikely explanation insofar as there was no beneficial effect until the 3rd/4th month. The occurrence of IRIS in two of them is highly suggestive to me of successful treatment of an immune-suppressing retrovirus. Could this be a HERV?
I now have 6 other patients on tenofovir, but all are within 3 months of starting the drug, and I do not expect any beneficial effects as yet. I intend to report on these when they have completed 4 months of treatment.
Of interest is that the apparent beneficial effects in Rituximab treated patients took a minimum of 16 weeks to appear. With the benefit of some (informed) guesswork I think that a retrovirus is the root cause of ME/CFS and that its preferred residence are CD20 cells, just as the preferred residence of HIV are CD4 cells. I am very excited by the response of the patients I have described and feel very strongly that a full double blind, randomised, controlled trial with close monitoring of immunological parameters is now warranted using antiretroviral therapy. As I am now retired I am not in a position to organise this but would be very happy to provide input based on my experience of seeing approximately 2,000 patients with ME/CFS.
Excellent. Have been looking for this. Has anyone come across the tenofovir dose ?